![Diabetes mellitus in relation to colorectal tumor molecular subtypes: A pooled analysis of more than 9000 cases - Harlid - 2022 - International Journal of Cancer - Wiley Online Library Diabetes mellitus in relation to colorectal tumor molecular subtypes: A pooled analysis of more than 9000 cases - Harlid - 2022 - International Journal of Cancer - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/b7d2fa44-7cb0-4f2c-8812-177c63e21b66/ijc34015-toc-0001-m.jpg)
Diabetes mellitus in relation to colorectal tumor molecular subtypes: A pooled analysis of more than 9000 cases - Harlid - 2022 - International Journal of Cancer - Wiley Online Library
![Targeting the Tumor in Colorectal Cancer – Where do we Stand with Precision Medicine in 2020 | Published in healthbook TIMES Oncology Hematology Targeting the Tumor in Colorectal Cancer – Where do we Stand with Precision Medicine in 2020 | Published in healthbook TIMES Oncology Hematology](https://onco-hema.healthbooktimes.org/article/24829-targeting-the-tumor-in-colorectal-cancer-where-do-we-stand-with-precision-medicine-in-2020/attachment/62959.png)
Targeting the Tumor in Colorectal Cancer – Where do we Stand with Precision Medicine in 2020 | Published in healthbook TIMES Oncology Hematology
![PDF] Colorectal Cancer Primary Tumor Location Implications on Biological Therapy in Metastatic Colorectal Cancer | Semantic Scholar PDF] Colorectal Cancer Primary Tumor Location Implications on Biological Therapy in Metastatic Colorectal Cancer | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/50a4df542bd40adc614a990d8984a44bb22f05b5/3-Figure1-1.png)
PDF] Colorectal Cancer Primary Tumor Location Implications on Biological Therapy in Metastatic Colorectal Cancer | Semantic Scholar
![Immune checkpoint blockade therapy for BRAF mutant metastatic colorectal cancer: the efficacy, new strategies, and potential biomarkers | Discover Oncology Immune checkpoint blockade therapy for BRAF mutant metastatic colorectal cancer: the efficacy, new strategies, and potential biomarkers | Discover Oncology](https://media.springernature.com/m685/springer-static/image/art%3A10.1007%2Fs12672-023-00718-y/MediaObjects/12672_2023_718_Fig1_HTML.png)
Immune checkpoint blockade therapy for BRAF mutant metastatic colorectal cancer: the efficacy, new strategies, and potential biomarkers | Discover Oncology
![Cureus | Incidence of BRAF V600E Gene Mutation Among Lebanese Population in Melanoma and Colorectal Cancer: A Retrospective Study Between 2010 and 2019 | Article Cureus | Incidence of BRAF V600E Gene Mutation Among Lebanese Population in Melanoma and Colorectal Cancer: A Retrospective Study Between 2010 and 2019 | Article](https://assets.cureus.com/uploads/figure/file/446007/article_river_a37a6d30270611edb830d7b3bcf13278-melanoma2.png)
Cureus | Incidence of BRAF V600E Gene Mutation Among Lebanese Population in Melanoma and Colorectal Cancer: A Retrospective Study Between 2010 and 2019 | Article
![Clinical and prognostic features of patients with detailed RAS/BRAF-mutant colorectal cancer in Japan | BMC Cancer | Full Text Clinical and prognostic features of patients with detailed RAS/BRAF-mutant colorectal cancer in Japan | BMC Cancer | Full Text](https://media.springernature.com/m685/springer-static/image/art%3A10.1186%2Fs12885-021-08271-z/MediaObjects/12885_2021_8271_Fig2_HTML.png)
Clinical and prognostic features of patients with detailed RAS/BRAF-mutant colorectal cancer in Japan | BMC Cancer | Full Text
![Cancers | Free Full-Text | Conversion Strategy in Left-Sided RAS/BRAF Wild- Type Metastatic Colorectal Cancer Patients with Unresectable Liver-Limited Disease: A Multicenter Cohort Study Cancers | Free Full-Text | Conversion Strategy in Left-Sided RAS/BRAF Wild- Type Metastatic Colorectal Cancer Patients with Unresectable Liver-Limited Disease: A Multicenter Cohort Study](https://www.mdpi.com/cancers/cancers-14-05513/article_deploy/html/images/cancers-14-05513-g001-550.jpg)
Cancers | Free Full-Text | Conversion Strategy in Left-Sided RAS/BRAF Wild- Type Metastatic Colorectal Cancer Patients with Unresectable Liver-Limited Disease: A Multicenter Cohort Study
![BRAFV600E immunohistochemistry in conjunction with mismatch repair status predicts survival in patients with colorectal cancer | Modern Pathology BRAFV600E immunohistochemistry in conjunction with mismatch repair status predicts survival in patients with colorectal cancer | Modern Pathology](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fmodpathol.2013.200/MediaObjects/41379_2014_Article_BFmodpathol2013200_Fig1_HTML.jpg)
BRAFV600E immunohistochemistry in conjunction with mismatch repair status predicts survival in patients with colorectal cancer | Modern Pathology
![Therapeutic strategy in unresectable metastatic colorectal cancer: an updated review - Benoist Chibaudel, Christophe Tournigand, Franck Bonnetain, Hubert Richa, Magdalena Benetkiewicz, Thierry André, Aimery de Gramont, 2015 Therapeutic strategy in unresectable metastatic colorectal cancer: an updated review - Benoist Chibaudel, Christophe Tournigand, Franck Bonnetain, Hubert Richa, Magdalena Benetkiewicz, Thierry André, Aimery de Gramont, 2015](https://journals.sagepub.com/cms/10.1177/1758834015572343/asset/images/large/10.1177_1758834015572343-fig1.jpeg)
Therapeutic strategy in unresectable metastatic colorectal cancer: an updated review - Benoist Chibaudel, Christophe Tournigand, Franck Bonnetain, Hubert Richa, Magdalena Benetkiewicz, Thierry André, Aimery de Gramont, 2015
![IJMS | Free Full-Text | The Winding Roadmap of Biomarkers Toward Clinic: Lessons from Predictors of Resistance to Anti-EGFRs in Metastatic Colorectal Cancer IJMS | Free Full-Text | The Winding Roadmap of Biomarkers Toward Clinic: Lessons from Predictors of Resistance to Anti-EGFRs in Metastatic Colorectal Cancer](https://www.mdpi.com/ijms/ijms-19-02298/article_deploy/html/images/ijms-19-02298-g001.png)
IJMS | Free Full-Text | The Winding Roadmap of Biomarkers Toward Clinic: Lessons from Predictors of Resistance to Anti-EGFRs in Metastatic Colorectal Cancer
![Cells | Free Full-Text | KRAS and BRAF Mutations as Prognostic and Predictive Biomarkers for Standard Chemotherapy Response in Metastatic Colorectal Cancer: A Single Institutional Study Cells | Free Full-Text | KRAS and BRAF Mutations as Prognostic and Predictive Biomarkers for Standard Chemotherapy Response in Metastatic Colorectal Cancer: A Single Institutional Study](https://www.mdpi.com/cells/cells-09-00219/article_deploy/html/images/cells-09-00219-g001.png)
Cells | Free Full-Text | KRAS and BRAF Mutations as Prognostic and Predictive Biomarkers for Standard Chemotherapy Response in Metastatic Colorectal Cancer: A Single Institutional Study
![BRAF mutation and clinical outcome in colon cancer. A-C. Kaplan-Meier... | Download Scientific Diagram BRAF mutation and clinical outcome in colon cancer. A-C. Kaplan-Meier... | Download Scientific Diagram](https://www.researchgate.net/publication/51858638/figure/fig1/AS:601581271674885@1520439560238/BRAF-mutation-and-clinical-outcome-in-colon-cancer-A-C-Kaplan-Meier-curves-according-to.png)
BRAF mutation and clinical outcome in colon cancer. A-C. Kaplan-Meier... | Download Scientific Diagram
![Frontiers | Management of BRAF Gene Alterations in Metastatic Colorectal Cancer: From Current Therapeutic Strategies to Future Perspectives Frontiers | Management of BRAF Gene Alterations in Metastatic Colorectal Cancer: From Current Therapeutic Strategies to Future Perspectives](https://www.frontiersin.org/files/Articles/602194/fonc-11-602194-HTML/image_m/fonc-11-602194-g001.jpg)
Frontiers | Management of BRAF Gene Alterations in Metastatic Colorectal Cancer: From Current Therapeutic Strategies to Future Perspectives
![Cancers | Free Full-Text | BRAF Mutation in Colorectal Cancers: From Prognostic Marker to Targetable Mutation Cancers | Free Full-Text | BRAF Mutation in Colorectal Cancers: From Prognostic Marker to Targetable Mutation](https://www.mdpi.com/cancers/cancers-12-03236/article_deploy/html/images/cancers-12-03236-g001a.png)
Cancers | Free Full-Text | BRAF Mutation in Colorectal Cancers: From Prognostic Marker to Targetable Mutation
![The heterogeneous clinical and pathological landscapes of metastatic Braf-mutated colorectal cancer | Cancer Cell International | Full Text The heterogeneous clinical and pathological landscapes of metastatic Braf-mutated colorectal cancer | Cancer Cell International | Full Text](https://media.springernature.com/m685/springer-static/image/art%3A10.1186%2Fs12935-020-1117-2/MediaObjects/12935_2020_1117_Fig1_HTML.png)
The heterogeneous clinical and pathological landscapes of metastatic Braf-mutated colorectal cancer | Cancer Cell International | Full Text
![Molecular targeted therapy of BRAF-mutant colorectal cancer - Michel Ducreux, Ali Chamseddine, Pierre Laurent-Puig, Cristina Smolenschi, Antoine Hollebecque, Peggy Dartigues, Emmanuelle Samallin, Valérie Boige, David Malka, Maximiliano Gelli, 2019 Molecular targeted therapy of BRAF-mutant colorectal cancer - Michel Ducreux, Ali Chamseddine, Pierre Laurent-Puig, Cristina Smolenschi, Antoine Hollebecque, Peggy Dartigues, Emmanuelle Samallin, Valérie Boige, David Malka, Maximiliano Gelli, 2019](https://journals.sagepub.com/cms/10.1177/1758835919856494/asset/images/large/10.1177_1758835919856494-fig1.jpeg)
Molecular targeted therapy of BRAF-mutant colorectal cancer - Michel Ducreux, Ali Chamseddine, Pierre Laurent-Puig, Cristina Smolenschi, Antoine Hollebecque, Peggy Dartigues, Emmanuelle Samallin, Valérie Boige, David Malka, Maximiliano Gelli, 2019
![Kaplan-Meier curves for colorectal cancer patients with BRAF-wild-type... | Download Scientific Diagram Kaplan-Meier curves for colorectal cancer patients with BRAF-wild-type... | Download Scientific Diagram](https://www.researchgate.net/publication/262781238/figure/fig1/AS:213869785030662@1428001938190/Kaplan-Meier-curves-for-colorectal-cancer-patients-with-BRAF-wild-type-tumors-according.png)
Kaplan-Meier curves for colorectal cancer patients with BRAF-wild-type... | Download Scientific Diagram
![PANDA study demonstrates progression-free survival gain for FOLFOX + panitumumab and 5FU / LV + first-line panitumumab to RAS-BRAF wild-type elderly metastatic colorectal cancer patients - Onco Americas PANDA study demonstrates progression-free survival gain for FOLFOX + panitumumab and 5FU / LV + first-line panitumumab to RAS-BRAF wild-type elderly metastatic colorectal cancer patients - Onco Americas](https://www.oncoamericas.com/wp-content/uploads/2020/06/INGLES_GASTROINTESTINAL_First-line_FOLFOX_plus_panitumumab_PANDA_Noticias-Retangular.png)
PANDA study demonstrates progression-free survival gain for FOLFOX + panitumumab and 5FU / LV + first-line panitumumab to RAS-BRAF wild-type elderly metastatic colorectal cancer patients - Onco Americas
![Targeting the Tumor in Colorectal Cancer – Where do we Stand with Precision Medicine in 2020 | Published in healthbook TIMES Oncology Hematology Targeting the Tumor in Colorectal Cancer – Where do we Stand with Precision Medicine in 2020 | Published in healthbook TIMES Oncology Hematology](https://onco-hema.healthbooktimes.org/article/24829-targeting-the-tumor-in-colorectal-cancer-where-do-we-stand-with-precision-medicine-in-2020/attachment/62960.png)
Targeting the Tumor in Colorectal Cancer – Where do we Stand with Precision Medicine in 2020 | Published in healthbook TIMES Oncology Hematology
![Overview of molecular biomarkers in metastatic colorectal cancer. WT,... | Download Scientific Diagram Overview of molecular biomarkers in metastatic colorectal cancer. WT,... | Download Scientific Diagram](https://www.researchgate.net/publication/353400946/figure/fig1/AS:1048603242004482@1627017903645/Overview-of-molecular-biomarkers-in-metastatic-colorectal-cancer-WT-wild-type-MT.png)
Overview of molecular biomarkers in metastatic colorectal cancer. WT,... | Download Scientific Diagram
![RNF43 mutations predict response to anti-BRAF/EGFR combinatory therapies in BRAFV600E metastatic colorectal cancer | Nature Medicine RNF43 mutations predict response to anti-BRAF/EGFR combinatory therapies in BRAFV600E metastatic colorectal cancer | Nature Medicine](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41591-022-01976-z/MediaObjects/41591_2022_1976_Fig1_HTML.png)
RNF43 mutations predict response to anti-BRAF/EGFR combinatory therapies in BRAFV600E metastatic colorectal cancer | Nature Medicine
![Glimmers of Hope—New Strategies for Overcoming Treatment Resistance in Patients with BRAF V600E-mutated Metastatic Colorectal Cancer - touchONCOLOGY Glimmers of Hope—New Strategies for Overcoming Treatment Resistance in Patients with BRAF V600E-mutated Metastatic Colorectal Cancer - touchONCOLOGY](https://touchoncology.com/wp-content/uploads/sites/2/2020/07/Fig-1.jpg)